Next, Bellamy et al. [158] found that two T-cell lines (one CD4+ and the other CD8+), derived in the presence of IL2, but absence of antigen, from cerebrospinal fluid (CSF) of patients with progressive MS, subsequently responded most strongly to gangliosides. This evidence concerns the gene CD8A and myeloid sarcoma.